Dr. Pastores is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Eccles Street
Dublin 7
New York, NY 10028
Summary
- Dr. Gregory Pastores is an Adult Metabolic Disease Specialist in Dublin, Ireland He received his medical degree from University of Santo Tomas (1983). He also speaks multiple languages, including Filipino and Spanish. He specializes in clinical, biochemical and molecular genetics.
Clinical Expertise
- Fabry disease, Lysosomal storage diseases, Enzyme replacement therapy, Splenomegaly, Severity of illness index, Pain measurement
Education & Training
- Icahn School of Medicine at Mount Sinai1991 - 1992
- Mayo Clinic Foundation1989 - 1991
- Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Elmhurst)Residency, Pediatrics, 1986 - 1989
- University of Santo TomasClass of 1983
Certifications & Licensure
- NY State Medical License 1989 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Replagal Enzyme Replacement Therapy for Children With Fabry Disease Start of enrollment: 2004 Jun 10
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease Start of enrollment: 2008 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsLysosomal storage disorders: Clinical and therapeutic aspects.Gregory M Pastores
Handbook of Clinical Neurology. 2023-01-01 - 3 citationsAbnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.Eileen P. Treacy, Sebastian Vencken, Annet M. Bosch, Matthias Gautschi, M. Estela Rubio-Gozalbo
JIMD Reports. 2021-07-22 - 25 citationsLysosomal Acid Lipase Deficiency: Therapeutic OptionsGregory M. Pastores, Derralynn Hughes
Drug Design, Development and Therapy. 2020-02-11
Other Languages
- Filipino, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: